RTRX - Retrophin Stock Trading

Retrophin Inc.(NASDAQ: RTRX) stock trading, description, contact, officers and directors.

About Retrophin Inc.

Retrophin, Inc. OTCQB: RTRX New York based, biotechnology company focused on discovering and developing treatments for rare and life threatening diseases. Retrophin is currently developing treatments for Focal Segmental Glomerulosclerosis FSGS , Pantothenate Kinase Associated Neurodegeneration PKAN , Duchenne Muscular Dystrophy DMD , and Spinal Muscular Atrophy SMA .

Stock Information

Retrophin Inc. Company Name:

RTRX Stock Symbol:

NASDAQ Market:

Retrophin Inc. Website:

RTRX - Retrophin Stock Trading

RTRX RTRX Quote RTRX Short RTRX News RTRX Articles RTRX Message Board

Get RTRX Alerts

News, Short Squeeze, Breakout and More Instantly...

RTRX - Travere Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

SAN DIEGO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced completion of patient enrollment in the Phase 3 DUPLEX Study. The pivotal DUPLEX Study is evaluating the safety and efficacy of sparsentan for the treatment of focal segmental glomerulosclerosis...
RTRX - Retrophin Announces Corporate Name Change to Travere Therapeutics, Inc.

New name reflects dedication to patient- inspired mission of identifying, developing and delivering life-changing rare disease therapies Company’s s hares to t rade u nder n ew t icker s ymbol TVTX on Novem...
RTRX - Retrophin Completes Acquisition of Orphan Technologies

SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the completion of its previously announced acquisition of Orphan Technologies Limited, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58...